Today: 29 April 2026
Browse Category

NYSE:GIS 6 November 2025 - 6 January 2026

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 06.01.2026

Fermi (FRMI) closed at $9.50 after falling 37.3% over 30 days, despite a 17.4% gain in the past week. ASX mining stocks rallied as fund managers named copper, gold, lithium, and iron ore producers as top picks for 2026. Indian Sensex dropped 443 points, while Reliance Industries rose 0.7% after denying Russian oil shipment reports. An article highlighted Coca-Cola, Procter & Gamble, and General Mills as favored dividend stocks.
6 January 2026
····
General Mills Stock (NYSE: GIS) Jumps After Q2 FY2026 Earnings Beat: Outlook Reaffirmed, Analysts Map the Next Move

General Mills Stock (NYSE: GIS) Jumps After Q2 FY2026 Earnings Beat: Outlook Reaffirmed, Analysts Map the Next Move

General Mills shares rose about 3% to $48.52 Wednesday after fiscal Q2 results topped Wall Street estimates. Net sales fell 7% to $4.86 billion, with adjusted EPS down 21% to $1.10, but both beat consensus forecasts. The company reaffirmed its full-year outlook despite continued pressure from portfolio changes and higher brand investment.
17 December 2025
··
Yoplait YOP Drinkable Yogurt Recall in Canada: Full List of Affected Products, Best-Before Dates and What Shoppers Should Do – November 24, 2025

Yoplait YOP Drinkable Yogurt Recall in Canada: Full List of Affected Products, Best-Before Dates and What Shoppers Should Do – November 24, 2025

The Canadian Food Inspection Agency has recalled all flavours of Yoplait YOP 200 mL drinkable yogurt nationwide due to possible plastic contamination. The recall, issued November 22, is classified as Class 1, CFIA’s highest risk level. No injuries or illnesses have been reported. The recall covers single bottles and multi-packs with best-before dates up to January 1.
24 November 2025
·
McConnell’s Hemp Crackdown Collides With Retail THC Boom: Big Brands, 39 AGs, and Congress Face a ‘Hemp War’ (Nov. 6, 2025)

McConnell’s Hemp Crackdown Collides With Retail THC Boom: Big Brands, 39 AGs, and Congress Face a ‘Hemp War’ (Nov. 6, 2025)

The Consumer Brands Association, representing Coca‑Cola, Nestlé, and others, urged Congress to ban intoxicating hemp products in FY26 spending talks. Thirty-nine state attorneys general renewed calls to tighten hemp’s legal definition. The Senate previously removed a House-backed hemp ban from a key bill, but negotiations continue. Meanwhile, Circle K and Target are expanding hemp-THC beverage sales as states impose new restrictions.
6 November 2025
·····

Stock Market Today

  • Ceres Power Surges Past Rolls-Royce, Nvidia, BP in FTSE 250 Rally
    April 29, 2026, 9:27 AM EDT. Ceres Power (LSE:CWR) leads the FTSE 250 stock gains in 2026 with a staggering 176% rise year-to-date, far outpacing Rolls-Royce, Nvidia and BP. The clean energy tech firm, specializing in licensing advanced solid oxide fuel cell and hydrogen technology, posted a remarkable 933% gain over the last year. Despite declining revenues - £32.6 million in 2025 down from £51.9 million the previous year - and no expected profits in 2026 or 2027, investor enthusiasm is fueled by the AI-driven data center boom. Its recent collaboration with Centrica aims to deploy efficient on-site power solutions swiftly for AI hubs and logistics centers. This positions Ceres as a crucial 'picks and shovels' provider amid the AI energy surge. However, over five years, the stock remains down 55%, prompting debate on its current valuation.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop